These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31695118)

  • 1. Surface stabilized atorvastatin nanocrystals with improved bioavailability, safety and antihyperlipidemic potential.
    Sharma M; Mehta I
    Sci Rep; 2019 Nov; 9(1):16105. PubMed ID: 31695118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of different types of nano drug delivery systems of atorvastatin for the treatment of hyperlipidemia.
    Mathur M; Devi Vemula K
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2048-2060. PubMed ID: 30073852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats.
    Mahmoud MO; Aboud HM; Hassan AH; Ali AA; Johnston TP
    J Control Release; 2017 May; 254():10-22. PubMed ID: 28344015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin-loaded pro-nanolipospheres with ameliorated oral bioavailability and antidyslipidemic activity.
    Khafagy ES; Motawee AO; Ghorab MM; Gardouh AR
    Colloids Surf B Biointerfaces; 2023 Jul; 227():113361. PubMed ID: 37236085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Delivery of Atorvastatin Nanocrystals in PLGA based in situ Gel for Anti-Hyperlipidemic Efficacy.
    Kurakula M; Ahmed TA
    Curr Drug Deliv; 2016; 13(2):211-20. PubMed ID: 26549039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe-Loaded Nanostructured Lipid Carrier Based Formulation Ameliorates Hyperlipidaemia in an Experimental Model of High Fat Diet.
    Agrawal YO; Mahajan UB; Agnihotri VV; Nilange MS; Mahajan HS; Sharma C; Ojha S; Patil CR; Goyal SN
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33803259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of Gelucire®-Based Solid Dispersions of Atorvastatin Calcium: In Vitro Dissolution and In Vivo Bioavailability Study.
    Aldosari BN; Almurshedi AS; Alfagih IM; AlQuadeib BT; Altamimi MA; Imam SS; Hussain A; Alqahtani F; Elzayat E; Alshehri S
    AAPS PharmSciTech; 2021 May; 22(5):161. PubMed ID: 34031791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrosprayed Polymeric Nanospheres for Enhanced Solubility, Dissolution Rate, Oral Bioavailability and Antihyperlipidemic Activity of Bezafibrate.
    Sun R; Shen C; Shafique S; Mustapha O; Hussain T; Khan IU; Mehmood Y; Anwer K; Shahzad Y; Yousaf AM
    Int J Nanomedicine; 2020; 15():705-715. PubMed ID: 32099359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypolipidemic potential of perillaldehyde-loaded self-nanoemulsifying delivery system in high-fat diet induced hyperlipidemic mice: Formulation, in vitro and in vivo evaluation.
    Omari-Siaw E; Zhu Y; Wang H; Peng W; Firempong CK; Wang YW; Cao X; Deng W; Yu J; Xu X
    Eur J Pharm Sci; 2016 Mar; 85():112-22. PubMed ID: 26851382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimentally designed lyophilized dry emulsion tablets for enhancing the antihyperlipidemic activity of atorvastatin calcium: Preparation, in-vitro evaluation and in-vivo assessment.
    Salama AH; Basha M; El Awdan S
    Eur J Pharm Sci; 2018 Jan; 112():52-62. PubMed ID: 29117504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan based atorvastatin nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy.
    Kurakula M; El-Helw AM; Sobahi TR; Abdelaal MY
    Int J Nanomedicine; 2015; 10():321-34. PubMed ID: 25609947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of the Binary and Ternary Atorvastatin Solid Dispersions:
    Faraji E; Mohammadi M; Mahboobian MM
    Biomed Res Int; 2021; 2021():6644630. PubMed ID: 34527740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and optimization of surface stabilized cryptotanshinone nanocrystals with enhanced bioavailability.
    Zhao W; Ruan B; Sun X; Yu Z
    Front Pharmacol; 2023; 14():1122071. PubMed ID: 36817118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant progress in improving Atorvastatin dissolution rate: Physicochemical characterization and stability assessment of self-dispersible Atorvastatin/Tween 80® nanocrystals formulated through wet milling and freeze-drying.
    Rossetti A; Real DA; Barrientos BA; Allemandi DA; Paredes AJ; Real JP; Palma SD
    Int J Pharm; 2024 Jan; 650():123720. PubMed ID: 38110014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Characterization of Venetoclax Nanocrystals for Oral Bioavailability Enhancement.
    Kala SG; Chinni S
    AAPS PharmSciTech; 2021 Mar; 22(3):92. PubMed ID: 33683477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenolic profiles, antihyperglycemic, antihyperlipidemic, and antioxidant properties of pomegranate (Punica granatum) peel extract.
    El-Hadary AE; Ramadan MF
    J Food Biochem; 2019 Apr; 43(4):e12803. PubMed ID: 31353600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
    Rizwanullah M; Amin S; Ahmad J
    J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.